Public Profile

Labatec

Labatec, officially known as Labatec Pharma, is a prominent player in the pharmaceutical industry, headquartered in Switzerland (CH). Founded in 1999, the company has established a strong presence in Europe and beyond, focusing on the development and distribution of high-quality generic and specialty pharmaceuticals. Labatec is renowned for its innovative approach to drug formulation, particularly in the areas of oncology and pain management. Their core products, which include a range of injectable and oral medications, are distinguished by their rigorous quality standards and commitment to patient safety. With a reputation for excellence, Labatec has achieved significant milestones, including numerous regulatory approvals and partnerships that enhance its market position. The company continues to be a trusted name in the pharmaceutical sector, dedicated to improving healthcare outcomes globally.

DitchCarbon Score

How does Labatec's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

6

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Labatec's score of 6 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.

82%

Labatec's reported carbon emissions

Labatec, headquartered in Switzerland (CH), currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined in their initiatives. Without concrete data or commitments, it is challenging to assess their climate impact or sustainability efforts. However, it is essential for companies in the industry to establish clear climate strategies and reduction targets to align with global sustainability goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Labatec's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Labatec is headquartered in CH, which has a rank of very low, indicating very low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Labatec is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

ELITechGroup MDx LLC

US
Health Services
Updated 3 days ago

Eurofarma

BR
Health Services
Updated 9 days ago

Nanjing Pharmaceutical

CN
Health Services
Updated 10 days ago

Mybiotics Pharma Ltd

IL
Health Services
Updated 2 days ago

Refarmed Chemicals

CH
Health Services
Updated 10 days ago

Confa

CO
Health Services
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers